These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 23050467)

  • 1. Development of an enzyme-linked immunosorbent assay to detect chicken serum antibody to glycoprotein G of infectious laryngotracheitis virus.
    Shil NK; Markham PF; Noormohammadi AH; O'Rourke D; Devlin JM
    Avian Dis; 2012 Sep; 56(3):509-15. PubMed ID: 23050467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of infectious laryngotracheitis virus glycoproteins in Escherichia coli and their application in enzyme-linked immunosorbent assay.
    Chang PC; Chen KT; Shien JH; Shieh HK
    Avian Dis; 2002; 46(3):570-80. PubMed ID: 12243520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune responses to infectious laryngotracheitis virus.
    Coppo MJ; Hartley CA; Devlin JM
    Dev Comp Immunol; 2013 Nov; 41(3):454-62. PubMed ID: 23567343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of infectious laryngotracheitis virus antibodies by glycoprotein-specific ELISAs in chickens vaccinated with viral vector vaccines.
    Godoy A; Icard A; Martinez M; Mashchenko A; García M; El-Attrachea J
    Avian Dis; 2013 Jun; 57(2 Suppl):432-6. PubMed ID: 23901757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vivo safety and efficacy of a glycoprotein G-deficient candidate vaccine strain of infectious laryngotracheitis virus delivered via eye drop.
    Coppo MJ; Noormohammadi AH; Hartley CA; Gilkerson JR; Browning GF; Devlin JM
    Avian Pathol; 2011 Aug; 40(4):411-7. PubMed ID: 21812721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of chickens from Newcastle disease and infectious laryngotracheitis with a recombinant fowlpox virus co-expressing the F, HN genes of Newcastle disease virus and gB gene of infectious laryngotracheitis virus.
    Sun HL; Wang YF; Tong GZ; Zhang PJ; Miao DY; Zhi HD; Wang M; Wang M
    Avian Dis; 2008 Mar; 52(1):111-7. PubMed ID: 18459306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycoprotein-C-gene-deleted recombinant infectious laryngotracheitis virus expressing a genotype VII Newcastle disease virus fusion protein protects against virulent infectious laryngotracheitis virus and Newcastle disease virus.
    Wei X; Shao Y; Han Z; Sun J; Liu S
    Vet Microbiol; 2020 Nov; 250():108835. PubMed ID: 33011664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycoprotein D peptide-based diagnostic approach for the detection of avian infectious laryngotracheitis antibodies.
    Kumar V; Yadav K; Kumar R; Chaudhary N; Kumar S
    Avian Pathol; 2019 Dec; 48(6):602-609. PubMed ID: 31199165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation onto the correlation between systemic antibodies to surface glycoproteins of infectious laryngotracheitis virus (ILTV) and protective immunity.
    Sabir AJ; Adams TE; O'Rourke D; Devlin JM; Noormohammadi AH
    Vet Microbiol; 2019 Jan; 228():252-258. PubMed ID: 30593375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A recombinant Newcastle disease virus (NDV) expressing infectious laryngotracheitis virus (ILTV) surface glycoprotein D protects against highly virulent ILTV and NDV challenges in chickens.
    Kanabagatte Basavarajappa M; Kumar S; Khattar SK; Gebreluul GT; Paldurai A; Samal SK
    Vaccine; 2014 Jun; 32(28):3555-63. PubMed ID: 24793943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newcastle disease virus vectored infectious laryngotracheitis vaccines protect commercial broiler chickens in the presence of maternally derived antibodies.
    Yu Q; Spatz S; Li Y; Yang J; Zhao W; Zhang Z; Wen G; Garcia M; Zsak L
    Vaccine; 2017 Feb; 35(5):789-795. PubMed ID: 28052812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycoprotein G deficient infectious laryngotracheitis virus is a candidate attenuated vaccine.
    Devlin JM; Browning GF; Hartley CA; Gilkerson JR
    Vaccine; 2007 May; 25(18):3561-6. PubMed ID: 17316926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infectious Laryngotracheitis Virus Viral Chemokine-Binding Protein Glycoprotein G Alters Transcription of Key Inflammatory Mediators
    Coppo MJC; Devlin JM; Legione AR; Vaz PK; Lee SW; Quinteros JA; Gilkerson JR; Ficorilli N; Reading PC; Noormohammadi AH; Hartley CA
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29070686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuated infectious laryngotracheitis virus vaccines differ in their capacity to establish latency in the trigeminal ganglia of specific pathogen free chickens following eye drop inoculation.
    Thilakarathne DS; Coppo MJC; Hartley CA; Diaz-Méndez A; Quinteros JA; Fakhri O; Vaz PK; Devlin JM
    PLoS One; 2019; 14(3):e0213866. PubMed ID: 30921344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the replication and transmissibility of an infectious laryngotracheitis virus vaccine delivered via eye-drop or drinking-water.
    Coppo MJ; Devlin JM; Noormohammadi AH
    Avian Pathol; 2012; 41(1):99-106. PubMed ID: 22845327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and vaccine efficacy of a glycoprotein G deficient strain of infectious laryngotracheitis virus delivered in ovo.
    Legione AR; Coppo MJ; Lee SW; Noormohammadi AH; Hartley CA; Browning GF; Gilkerson JR; O'Rourke D; Devlin JM
    Vaccine; 2012 Nov; 30(50):7193-8. PubMed ID: 23084851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spray vaccination with a Newcastle disease virus (NDV)-vectored infectious laryngotracheitis (ILT) vaccine protects commercial chickens from ILT in the presence of maternally-derived antibodies.
    Zeng Z; Wang Z; Wang X; Yao L; Shang Y; Feng H; Wang H; Shao H; Luo Q; Wen G
    Avian Pathol; 2024 Dec; 53(6):533-539. PubMed ID: 38836447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of live virus vaccines against infectious laryngotracheitis assessed by polymerase chain reaction-restriction fragment length polymorphism.
    Han MG; Kim SJ
    Avian Dis; 2003; 47(2):261-71. PubMed ID: 12887186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single Nucleotide Polymorphism Genotyping Analysis Shows That Vaccination Can Limit the Number and Diversity of Recombinant Progeny of Infectious Laryngotracheitis Viruses from the United States.
    Loncoman CA; Hartley CA; Coppo MJC; Browning GF; Beltrán G; Riblet S; Freitas CO; García M; Devlin JM
    Appl Environ Microbiol; 2018 Dec; 84(23):. PubMed ID: 30242009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of immunological responses to a glycoprotein G deficient candidate vaccine strain of infectious laryngotracheitis virus.
    Devlin JM; Viejo-Borbolla A; Browning GF; Noormohammadi AH; Gilkerson JR; Alcami A; Hartley CA
    Vaccine; 2010 Feb; 28(5):1325-32. PubMed ID: 19932672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.